| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1014561904 |
| P356 | DOI | 10.1038/SJ.MP.4001969 |
| P698 | PubMed publication ID | 17353912 |
| P5875 | ResearchGate publication ID | 6453044 |
| P50 | author | Guy A. Rouleau | Q3121500 |
| P2093 | author name string | Turecki G | |
| Benkelfat C | |||
| Canetti L | |||
| ffrench-Mullen J | |||
| Klempan T | |||
| Sequeira A | |||
| P2860 | cites work | Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE | Q22010705 |
| BACE (beta-secretase) modulates the processing of APLP2 in vivo | Q24336570 | ||
| Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes | Q24534395 | ||
| Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22. | Q24536203 | ||
| Hippocampal atrophy in recurrent major depression | Q24598190 | ||
| Significance analysis of microarrays applied to the ionizing radiation response | Q24606608 | ||
| Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex | Q28138248 | ||
| GABA and glutamate in the human brain | Q28216691 | ||
| Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders | Q28240591 | ||
| Molecular correlates of emotional learning using genetically selected rat lines | Q28568691 | ||
| Altered hippocampal short-term plasticity and associative memory in synaptotagmin IV (-/-) mice | Q28590866 | ||
| Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants | Q29547516 | ||
| Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus | Q29619400 | ||
| Prefrontal cortical-amygdalar metabolism in major depression | Q30579598 | ||
| A molecular and cellular theory of depression | Q34064955 | ||
| The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death | Q34076866 | ||
| Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression | Q34084102 | ||
| Reduced volume of orbitofrontal cortex in major depression | Q34124198 | ||
| The neurobiology and genetics of suicide and attempted suicide: a focus on the serotonergic system | Q34204641 | ||
| The cellular neurobiology of depression | Q34236134 | ||
| Course of illness, hippocampal function, and hippocampal volume in major depression | Q34331120 | ||
| Suicidal behavior: is there a genetic predisposition? | Q34530102 | ||
| Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy | Q34544344 | ||
| Wolframin mutations and hospitalization for psychiatric illness | Q34557061 | ||
| Psychiatric findings in Wolfram syndrome homozygotes | Q34611923 | ||
| Synaptic plasticity and mood disorders | Q34622373 | ||
| Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders | Q34994209 | ||
| Neuroimaging Abnormalities in the Amygdala in Mood Disorders | Q35118453 | ||
| GABAergic dysfunction in mood disorders. | Q35187929 | ||
| Childhood trauma associated with smaller hippocampal volume in women with major depression. | Q35591603 | ||
| The stress system in the human brain in depression and neurodegeneration | Q36183541 | ||
| Glial reduction in the subgenual prefrontal cortex in mood disorders | Q36651128 | ||
| Multiple significance tests: the Bonferroni method | Q36901984 | ||
| Dysregulation of the fibroblast growth factor system in major depression | Q37585523 | ||
| Acute amygdalar activation induces an upregulation of multiple monoamine G protein coupled pathways in rat hippocampus | Q38340649 | ||
| Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder | Q38350959 | ||
| Gene expression profile of aging in human muscle | Q38353969 | ||
| Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: a gene ontology study | Q38519890 | ||
| Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder | Q38841364 | ||
| Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment | Q39128639 | ||
| Amygdala and hippocampus volumes in pediatric major depression. | Q40460228 | ||
| The suicide brain: a review of postmortem receptor/transporter binding studies | Q40851508 | ||
| The epidemiology of suicide and parasuicide. | Q40920096 | ||
| The neurobiology of suicide | Q41680290 | ||
| Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects | Q43594315 | ||
| Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims | Q43899455 | ||
| Response of cortical metabolic deficits to serotonergic challenge in familial mood disorders | Q44265278 | ||
| Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjects | Q44352569 | ||
| Suicide in major depression | Q44408726 | ||
| Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects | Q44545444 | ||
| Gene expression profiling of depression and suicide in human prefrontal cortex | Q44645820 | ||
| Protein kinase A in postmortem brain of depressed suicide victims: altered expression of specific regulatory and catalytic subunits | Q44742894 | ||
| Altered 5-HT2A and 5-HT4 postsynaptic receptors and their intracellular signalling systems IP3 and cAMP in brains from depressed violent suicide victims | Q44876128 | ||
| Decreased catalytic activity and expression of protein kinase C isozymes in teenage suicide victims: a postmortem brain study | Q47240779 | ||
| ??? | Q59148640 | ||
| Reduced synaptic vesicle density and active zone size in mice lacking amyloid precursor protein (APP) and APP-like protein 2. | Q47380653 | ||
| Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis | Q47890327 | ||
| Molecular evidence for mitochondrial dysfunction in bipolar disorder | Q48017201 | ||
| G Protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: effects of diagnosis, suicide, and treatment at the time of death | Q48127856 | ||
| Hippocampal/amygdala volumes in geriatric depression | Q48164078 | ||
| Altered expression and phosphorylation of myristoylated alanine-rich C kinase substrate (MARCKS) in postmortem brain of suicide victims with or without depression | Q48258941 | ||
| Larger amygdala volumes in first depressive episode as compared to recurrent major depression and healthy control subjects | Q48388265 | ||
| Amygdala core nuclei volumes are decreased in recurrent major depression | Q48425334 | ||
| Hippocampal changes in patients with a first episode of major depression | Q48564609 | ||
| Enlargement of the amygdala in patients with a first episode of major depression | Q48619140 | ||
| Volumetric reduction in left subgenual prefrontal cortex in early onset depression | Q48628812 | ||
| Effect of sertraline on regional metabolic rate in patients with affective disorder | Q48823191 | ||
| Reduced [3H]cyclic AMP binding in postmortem brain from subjects with bipolar affective disorder. | Q48824537 | ||
| The hippocampus and parahippocampus in schizophrenia, suicide, and control brains | Q48865844 | ||
| Variations in differential gene expression patterns across multiple brain regions in schizophrenia | Q48879967 | ||
| Cyclic AMP-mediated signaling components are upregulated in the prefrontal cortex of depressed suicide victims | Q48913694 | ||
| Reduced anxiety and depression-like behavior in synaptotagmin IV (-/-) mice. | Q50992095 | ||
| Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region. | Q51039593 | ||
| Familial aggregation of suicidal behavior: a family study of male suicide completers from the general population. | Q51930584 | ||
| A missense polymorphism (S205L) of the low-affinity neurotrophin receptor p75NTR gene is associated with depressive disorder and attempted suicide. | Q51938921 | ||
| Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. | Q51980100 | ||
| Suicide and mental disorders: a case-control study of young men. | Q52025503 | ||
| Hippocampal volume reduction in major depression. | Q52172075 | ||
| 3',5' cyclic adenosine monophosphate in depression and mania. | Q53808720 | ||
| Hippocampal volume in primary unipolar major depression: a magnetic resonance imaging study. | Q54047414 | ||
| Volumetric Analysis of the Prefrontal Cortex, Amygdala and Hippocampus in Major Depression | Q61834282 | ||
| State changes in brain activity shown by the uptake of 99mTc-exametazime with single photon emission tomography in major depression before and after treatment | Q64446779 | ||
| Linkage disequilibrium analysis of childhood-onset spinal muscular atrophy (SMA) in the French-Canadian population | Q72017400 | ||
| Wolfram syndrome and suicide: Evidence for a role of WFS1 in suicidal and impulsive behavior | Q73300996 | ||
| Reduced adenylyl cyclase immunolabeling and activity in postmortem temporal cortex of depressed suicide victims | Q73508034 | ||
| Quantitative MRI of the hippocampus and amygdala in severe depression | Q73560010 | ||
| Hippocampal volume in geriatric depression | Q74227453 | ||
| Lower hippocampal volume in patients suffering from depression: a meta-analysis | Q79851071 | ||
| Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder | Q80433360 | ||
| Microarray analysis of postmortem temporal cortex from patients with schizophrenia | Q80502608 | ||
| Enlarged amygdala volume and reduced hippocampal volume in young women with major depression | Q81035260 | ||
| ERK MAP kinase signaling in post-mortem brain of suicide subjects: differential regulation of upstream Raf kinases Raf-1 and B-Raf | Q81236740 | ||
| The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia | Q81481442 | ||
| Gene expression microarray studies in polygenic psychiatric disorders: applications and data analysis | Q81866364 | ||
| Implication of SSAT by gene expression and genetic variation in suicide and major depression | Q82150935 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | suicide | Q10737 |
| P304 | page(s) | 640-655 | |
| P577 | publication date | 2007-03-13 | |
| P1433 | published in | Molecular Psychiatry | Q6895973 |
| P1476 | title | Patterns of gene expression in the limbic system of suicides with and without major depression | |
| P478 | volume | 12 |
| Q29417101 | A genome-wide association study of attempted suicide. |
| Q42374288 | A new stress sensor and risk factor for suicide: the T allele of the functional genetic variant in the GABRA6 gene |
| Q36385728 | A pilot genome wide association and gene expression array study of suicide with and without major depression |
| Q36852624 | A pilot integrative genomics study of GABA and glutamate neurotransmitter systems in suicide, suicidal behavior, and major depressive disorder |
| Q45891785 | Administration of clomipramine to neonatal mice alters stress response behavior and serotonergic gene expressions in adult mice |
| Q94452523 | Altered GABA-mediated information processing and cognitive dysfunctions in depression and other brain disorders |
| Q33789009 | Altered Organization of GABA(A) Receptor mRNA Expression in the Depressed Suicide Brain |
| Q35162791 | Altered choroid plexus gene expression in major depressive disorder |
| Q34084772 | Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression |
| Q35688931 | Altered expression of neuroplasticity-related genes in the brain of depressed suicides |
| Q28485508 | Altered functional protein networks in the prefrontal cortex and amygdala of victims of suicide |
| Q36818584 | Altered metabolic activity in the developing brain of rats predisposed to high versus low depression-like behavior |
| Q33854240 | Altered miRNA expression network in locus coeruleus of depressed suicide subjects |
| Q38245264 | An overview of the neurobiology of suicidal behaviors as one meta-system. |
| Q47402953 | Assessment of Whole-Exome Sequence Data in Attempted Suicide within a Bipolar Disorder Cohort. |
| Q33770054 | Association of polyaminergic loci with anxiety, mood disorders, and attempted suicide |
| Q90288532 | Brain Gene Expression Pattern of Subjects with Completed Suicide and Comorbid Substance Use Disorder |
| Q28552470 | Brain Microstructural Abnormalities Are Related to Physiological Alterations in End-Stage Renal Disease |
| Q36593796 | Concordance of psychiatric symptom ratings between a subject and informant, relevancy to post-mortem research |
| Q30511829 | Convergent functional genomic studies of ω-3 fatty acids in stress reactivity, bipolar disorder and alcoholism |
| Q64102147 | Cortical GABAergic Dysfunction in Stress and Depression: New Insights for Therapeutic Interventions |
| Q88498642 | Cortical inhibitory markers of lifetime suicidal behavior in depressed adolescents |
| Q34828363 | Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders |
| Q34615783 | Defects in dendrite and spine maturation and synaptogenesis associated with an anxious-depressive-like phenotype of GABAA receptor-deficient mice |
| Q39139500 | Differential effect of lithium on spermidine/spermine N1-acetyltransferase expression in suicidal behaviour |
| Q28296874 | Discovery and validation of blood biomarkers for suicidality |
| Q37159338 | Early parental deprivation in the marmoset monkey produces long-term changes in hippocampal expression of genes involved in synaptic plasticity and implicated in mood disorder. |
| Q34225213 | Effects of histone modifications on increased expression of polyamine biosynthetic genes in suicide |
| Q34254501 | Epigenetic signaling in psychiatric disorders. |
| Q34426179 | Epigenetic signaling in psychiatric disorders: stress and depression. |
| Q52651245 | Estrogen receptor α drives pro-resilient transcription in mouse models of depression. |
| Q90400535 | Etiopathogenesis of Suicide: A Conceptual Analysis of Risk and Prevention Within a Comprehensive, Deterministic Model |
| Q89475552 | Evidence of Reduced Agmatine Concentrations in the Cerebral Cortex of Suicides |
| Q33868443 | Evidence of altered polyamine concentrations in cerebral cortex of suicide completers |
| Q41576968 | Expression of p21-activated kinases 1 and 3 is altered in the brain of subjects with depression |
| Q35661134 | Expression profiling in neuropsychiatric disorders: emphasis on glutamate receptors in bipolar disorder |
| Q27013597 | Functional regulation of GABAA receptors in nervous system pathologies |
| Q36073289 | GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders |
| Q36668325 | GABAergic control of depression-related brain states |
| Q35922818 | Gene expression changes in the prefrontal cortex, anterior cingulate cortex and nucleus accumbens of mood disorders subjects that committed suicide |
| Q28471583 | Gene expression in human hippocampus from cocaine abusers identifies genes which regulate extracellular matrix remodeling |
| Q33523164 | Gene expression profiling in C57BL/6J and A/J mouse inbred strains reveals gene networks specific for brain regions independent of genetic background |
| Q33762208 | Gene expression studies in major depression. |
| Q43199178 | Genetic and epigenetic influences on expression of spermine synthase and spermine oxidase in suicide completers |
| Q37191419 | Genome-wide epigenetic regulation by early-life trauma. |
| Q48933889 | Global gene expression profiling of the polyamine system in suicide completers |
| Q46443602 | Glutamatergic GRIN2B and polyaminergic ODC1 genes in suicide attempts: associations and gene-environment interactions with childhood/adolescent physical assault. |
| Q34674688 | Hyperthermia-induced disruption of functional connectivity in the human brain network |
| Q37106189 | Implication of the polyamine system in mental disorders |
| Q34731214 | Inflammation and lithium: clues to mechanisms contributing to suicide-linked traits |
| Q35150183 | Investigation of blood mRNA biomarkers for suicidality in an independent sample |
| Q37147332 | Is brain banking of psychiatric cases valuable for neurobiological research? |
| Q28604131 | Isoform-level brain expression profiling of the spermidine/spermine N1-Acetyltransferase1 (SAT1) gene in major depression and suicide |
| Q37292968 | MEIS1 intronic risk haplotype associated with restless legs syndrome affects its mRNA and protein expression levels |
| Q59812788 | Magnetic seizure therapy reduces suicidal ideation and produces neuroplasticity in treatment-resistant depression |
| Q101038795 | Mitochondrial gene signature in the prefrontal cortex for differential susceptibility to chronic stress |
| Q36079812 | Molecular Mechanism for Stress-Induced Depression Assessed by Sequencing miRNA and mRNA in Medial Prefrontal Cortex |
| Q34460470 | Molecular pathway reconstruction and analysis of disturbed gene expression in depressed individuals who died by suicide |
| Q27339187 | Nature and nurture: environmental influences on a genetic rat model of depression |
| Q38659366 | Neuropathology of suicide: recent findings and future directions. |
| Q90532524 | Parvalbumin Promoter Methylation Altered in Major Depressive Disorder |
| Q38998251 | Prefrontal Cortex GABAergic Deficits and Circuit Dysfunction in the Pathophysiology and Treatment of Chronic Stress and Depression |
| Q57190989 | Preliminary evidence of an association between increased cortical inhibition and reduced suicidal ideation in adolescents treated for major depression |
| Q46482293 | Profiling of behavioral changes and hippocampal gene expression in mice chronically treated with the SSRI paroxetine |
| Q21144321 | Promoter-wide hypermethylation of the ribosomal RNA gene promoter in the suicide brain |
| Q38443525 | RNA-sequencing profiles hippocampal gene expression in a validated model of cancer-induced depression. |
| Q41646482 | Reduced GABA neuron density in auditory cerebral cortex of subjects with major depressive disorder. |
| Q45793667 | Regulatory role of miRNAs in polyamine gene expression in the prefrontal cortex of depressed suicide completers |
| Q36591265 | Responder and nonresponder patients exhibit different peripheral transcriptional signatures during major depressive episode |
| Q47641958 | Sex-specific transcriptional signatures in human depression |
| Q90311316 | Shared Transcriptional Signatures in Major Depressive Disorder and Mouse Chronic Stress Models |
| Q38138118 | Suicide and the polyamine system |
| Q38687599 | Systems Genomics Support for Immune and Inflammation Hypothesis of Depression. |
| Q37175279 | Target identification for CNS diseases by transcriptional profiling. |
| Q38815980 | Targets of polyamine dysregulation in major depression and suicide: Activity-dependent feedback, excitability, and neurotransmission. |
| Q44564191 | The 2009 Nobel conference on the role of genetics in promoting suicide prevention and the mental health of the population |
| Q37810015 | The Epigenetics of Suicide: Explaining the Biological Effects of Early Life Environmental Adversity |
| Q30464954 | The GABAergic deficit hypothesis of major depressive disorder. |
| Q34470397 | The neurobiology of suicide - A Review of post-mortem studies |
| Q34130553 | The role of proteomics in depression research |
| Q37668029 | Towards the Molecular Foundations of Glutamatergic-targeted Antidepressants |
| Q47569935 | Treatment resistant depression: A multi-scale, systems biology approach |
| Q39005702 | Understanding epigenetic architecture of suicide neurobiology: A critical perspective |
| Q37347723 | Variable telomere length across post-mortem human brain regions and specific reduction in the hippocampus of major depressive disorder |
| Q38443715 | Whole-transcriptome brain expression and exon-usage profiling in major depression and suicide: evidence for altered glial, endothelial and ATPase activity |
| Q48378958 | X chromosome and suicide. |
| Q57804915 | iTRAQ-Based Quantitative Proteomics Suggests Synaptic Mitochondrial Dysfunction in the Hippocampus of Rats Susceptible to Chronic Mild Stress |
| Q33864410 | miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment |
Search more.